TCF vs. HARL, ING, SPO, IX, NWT, TREE, STL, HWC, AGM, and FCRM
Should you be buying Theracryf stock or one of its competitors? The main competitors of Theracryf include Harland & Wolff Group (HARL), Ingenta (ING), Sportech (SPO), i(x) Net Zero (IX), Newmark Security (NWT), Cambium Global Timberland (TREE), Stilo International (STL), Highway Capital (HWC), Applied Graphene Materials (AGM), and Fulcrum Utility Services (FCRM). These companies are all part of the "banking" industry.
Theracryf vs.
Theracryf (LON:TCF) and Harland & Wolff Group (LON:HARL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, community ranking, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.
Theracryf and Harland & Wolff Group both received 0 outperform votes by MarketBeat users.
In the previous week, Theracryf had 1 more articles in the media than Harland & Wolff Group. MarketBeat recorded 1 mentions for Theracryf and 0 mentions for Harland & Wolff Group. Theracryf's average media sentiment score of 0.00 beat Harland & Wolff Group's score of -0.80 indicating that Theracryf is being referred to more favorably in the media.
Theracryf has higher earnings, but lower revenue than Harland & Wolff Group. Theracryf is trading at a lower price-to-earnings ratio than Harland & Wolff Group, indicating that it is currently the more affordable of the two stocks.
Theracryf has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Comparatively, Harland & Wolff Group has a beta of 3.14, suggesting that its stock price is 214% more volatile than the S&P 500.
Theracryf has a net margin of 0.00% compared to Harland & Wolff Group's net margin of -49.57%. Harland & Wolff Group's return on equity of 0.00% beat Theracryf's return on equity.
37.0% of Theracryf shares are owned by institutional investors. Comparatively, 60.8% of Harland & Wolff Group shares are owned by institutional investors. 42.9% of Theracryf shares are owned by insiders. Comparatively, 16.3% of Harland & Wolff Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Theracryf and Harland & Wolff Group tied by winning 6 of the 12 factors compared between the two stocks.
Get Theracryf News Delivered to You Automatically
Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Theracryf Competitors List
Related Companies and Tools
This page (LON:TCF) was last updated on 1/21/2025 by MarketBeat.com Staff
